{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:25:10Z","timestamp":1790961910270,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>RhD alloimmunization can result from blood transfusion or fetomaternal hemorrhage (FMH). Preventing alloimmunization in childbearing\u2010age women with FMH via utilization of RhD immunoglobulin (RhIG) is well known; however, there are no established protocols for RhD\u2010mismatched transfusions in emergent or traumatic settings. Here, we describe our hospital protocol for managing RhD negative women who receive RhD positive transfusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Pathology or Transfusion Medicine staff are notified of RhD\u2010mismatched blood transfusions. Women with childbearing potential are evaluated by Obstetrics and Gynecology (ObGyn) to determine patients' childbearing desires and physical capabilities, as well as their ability to tolerate RhIG administration. Pathologists determine eligibility for therapy with RhIG: criteria include RhD negative females, &lt;50\u2009years old, without current or historical Anti\u2010D, who have been transfused &lt;20% of their total blood volume (TBV) with RhD positive blood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Management strategy depends on red blood cell volume (RBCv) transfused. Patients who receive an RBCv \u226420% of their TBV are eligible to receive RhIG, while an RBCv &gt;20% makes individuals ineligible for prophylaxis with RhIG. Red cell exchange (RCX) is not offered at our institution, regardless of RBCv transfused. Women who receive RhIG should be screened for the development of antibodies using direct and indirect antiglobulin tests for 6\u201312\u2009months posttransfusion. Future pregnancies of alloimmunized women should be carefully monitored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our therapeutic plan involves identifying eligible patients based on set criteria. This is the first published protocol to prevent RhD alloimmunization in females of childbearing age due to RhD\u2010mismatched transfusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.18181","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T14:09:07Z","timestamp":1743343747000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["How I do it: An institutional protocol for the management of\n                    <scp>RhD<\/scp>\n                    negative women who receive\n                    <scp>RhD<\/scp>\n                    positive blood"],"prefix":"10.1111","volume":"65","author":[{"given":"Rahaf","family":"Alkhateb","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6484-629X","authenticated-orcid":false,"given":"Kirea","family":"Mazzolini","sequence":"additional","affiliation":[{"name":"Department of Surgery UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipulkumar Pravinbhai","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla E.","family":"Ireland","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Surgery UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Daniels","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Greebon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470986868"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002528"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00394.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198906000-00015"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00289.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13169"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13158"},{"issue":"1","key":"e_1_2_6_9_1","first-page":"S185","article-title":"Rate of D\u2010alloimmunization in trauma does not depend on the number of Rhd positive units transfused: the BEST collaborative study","volume":"62","author":"Seheult JN","year":"2022","journal-title":"Transfusion"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.1905395"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13232"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01446.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01700.x"},{"issue":"1","key":"e_1_2_6_14_1","first-page":"S150","article-title":"Rate of RhD\u2010alloimmunization after the transfusion of multiple RhD\u2010positive primary red blood cell\u2010containing products","volume":"61","author":"Yazer MH","year":"2021","journal-title":"Transfusion"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1054\/blre.1999.0123"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12091"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90232-5"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7122.1588"},{"key":"e_1_2_6_19_1","unstructured":"Bern Switzerland: CSL Behring AG. Rhophylac (Rh0[D] immune globulin intravenous[human]) package insert.2012."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<245::AID-AJH16>3.0.CO;2-4"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001905"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03338.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000004382"},{"key":"e_1_2_6_24_1","unstructured":"LivingstonG.They're waiting longer but U.S. women today more likely to have children than a decade ago.2018https:\/\/www.pewsocialtrends.org\/2018\/01\/18\/theyre\u2010waiting\u2010longer\u2010but\u2010u\u2010s\u2010women\u2010today\u2010more\u2010likely\u2010to\u2010have\u2010children\u2010than\u2010a\u2010decade\u2010ago\/Accessed May 25 2020."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5355"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21705"},{"key":"e_1_2_6_27_1","volume-title":"Henry's clinical diagnosis and management by laboratory methods","author":"McPherson R","year":"2017"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140288"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803531-3.00002-1"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.3.281"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20225"},{"key":"e_1_2_6_32_1","unstructured":"Roswell GA: Saol Therapeutics Inc.WinRho SDF [Rh0(D) Immune Globulin Intravenous (Human)] package insert.2019."},{"key":"e_1_2_6_33_1","unstructured":"Kedrion Biopharma.Rh0(D) Immune Globulin (Human) RhoGAM package insert. Melville NY.2022."},{"key":"e_1_2_6_34_1","unstructured":"Barcelona Spain. Grifols. HyperRHO S\/D [Rh0(D) Immune Globulin (Human)]."},{"issue":"4","key":"e_1_2_6_35_1","first-page":"681","article-title":"Prognosis and Management in Subsequent Rh Alloimmunized Pregnancies","volume":"16","author":"Dumitru A","year":"2021","journal-title":"Maedica (Bucur)"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17700"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04161.x"},{"key":"e_1_2_6_38_1","first-page":"646","volume-title":"Technical manual","author":"Fung MK","year":"2017"},{"key":"e_1_2_6_39_1","unstructured":"Terumo Corporation.Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA\u20101) \u2010 anticoagulant citrate phosphate dextrose adenine (CPDA\u20101) solution terumo corporation.2018https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b6f4a15\u2010https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b6f4a15\u20107bb0\u20104092\u2010b43d\u2010b423f14ec12f\u20104092\u2010b43d\u2010b423f14ec12fAccessed May 2020."},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.02158.x"},{"issue":"5","key":"e_1_2_6_41_1","first-page":"293","article-title":"Anti\u2010Rh therapy after transfusion","volume":"8","author":"Keith L","year":"1972","journal-title":"J Reprod Med"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.18181","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.18181","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.18181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:22:39Z","timestamp":1789654959000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.18181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":40,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/trf.18181"],"URL":"https:\/\/doi.org\/10.1111\/trf.18181","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"2024-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}